Terms ending in 2028
Every in-force patent on Biodesix, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,024,282 | Method for Reliable Classification of Samples in Clinical Diagnostics Using an Improved Method of Classification In force · High confidence | Biodesix Inc. | In force | High confidence | |
| US 7,736,905 | Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease In force · High confidence | Biodesix, Inc., a Delaware Corporation | In force | High confidence | |
| US 9,152,758 | Method and system for determining whether a drug will be effective on a patient with a disease In force · High confidence | Biodesix Inc. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.